TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
Home
Press release
Feb 07, 2019 09:00 JST
Source:
Lubrizol
Lubrizol LifeSciences to Showcase New Medical Device Applications Lab at MDM West 2019
CLEVELAND, Ohio, Feb 07, 2019 - (ACN Newswire) - The Lubrizol Corporation announces its LifeSciences business will feature a new medical device applications lab. LifeSciences has invested significantly to expand its global development and manufacturing facilities, and the latest investment is a new state-of-the-art medical device applications lab in Brecksville, Ohio. This lab features applications testing, small-scale compounding as well as injection molding for long-term implantables. The 1,800-square foot facility will also focus on accelerated R&D, from polymers to device scale up and testing in a short period of time.
The medical device applications lab is yet another substantial piece of LifeSciences' full-service capabilities. These capabilities and more will be on display at the MD&M West Exposition (Booth #2401), February 5-7. Lubrizol LifeSciences is a preferred medical device development partner, helping customers from concept to commercialization by offering polymer customization, drug-eluting device development and contract manufacturing services. At MD&M, LifeSciences will also highlight a strong presence in the interventional catheter, long-term implant and drug-eluting device markets. In addition, LifeSciences will unveil new dexamethasone-loaded polymers designed to minimize inflammation and help ensure the success of implantable medical devices.
"The new applications lab is another commitment to healthcare companies looking for a full-service development partner. We continue to invest in the right areas to provide valuable offerings where our customers are experiencing the most growth," states Uwe Winzen, general manager, Lubrizol LifeSciences. "When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process."
Offering more than 90 years of science and technology experience, Lubrizol is uniquely structured to partner with medical device manufacturers by providing proactive innovation, speed to market, and expertise for the most demanding projects. From materials to development and manufacturing, or anything in between - Lubrizol LifeSciences is equipped to support the needs of customers worldwide.
About Lubrizol LifeSciences
Lubrizol LifeSciences is a preferred Contract Development and Manufacturing Organization (CDMO) partner for complex pharmaceuticals and high-end medical devices providing differentiated polymers and excipients, along with state-of-the-art design, development and manufacturing services to the healthcare industry.
About The Lubrizol Corporation
The Lubrizol Corporation, a Berkshire Hathaway company, is a market-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It is a leader at combining market insights with chemistry and application capabilities to deliver valuable solutions to customers in the global transportation, industrial and consumer markets. Lubrizol improves lives by acting as an essential partner in our customers' success, delivering efficiency, reliability or wellness to their end users. Technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care, personal care and skin care products and specialty materials encompassing polymer and coatings technologies, along with polymer-based pharmaceutical and medical device solutions.
With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 8,700 employees worldwide. Revenues for 2017 were $6.3 billion. For more information, visit Lubrizol.com.
Media Contact
Ben Patti
(216) 447-5827
[email protected]
www.lubrizol.com/LifeSciences
###
This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via Globenewswire
Source: Lubrizol
Copyright ©2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Related Press Release
Lubrizol Announces Global Collaboration with Corbion
June 18 2019 16:30 JST
Particle Sciences Expands Controlled Substance Capabilities with Approval of DEA Schedule I Registration
May 29 2019 10:00 JST
Lubrizol to Present at the 29th CIMAC World Congress 2019
May 29 2019 10:00 JST
Lubrizol Aims at Circular Economy with TPU Solutions for Footwear
May 17 2019 08:00 JST
Lubrizol Announces Collaboration with Ultimaker's Material Alliance Program
May 15 2019 09:00 JST
Ground Breaking Ceremony at New Lubrizol LUCANT Plant
April 30 2019 08:00 JST
Lubrizol's Diamond Dispersions Business Wins Queen's Award for International Trade
April 23 2019 23:00 JST
Lubrizol to Feature New Bio TPU Grades for 3D Printing and Molded Parts at Plastteknik Fair 2019
April 18 2019 07:30 JST
Lubrizol is Ready for ILSAC GF-6 - Announcing Lubrizol(R) PV1510 Additive Technology for the GF-6 Specification
April 16 2019 07:00 JST
Lubrizol Showcases Renewable-Sourced Estane(R) 3D ECO TPU for 3D Printing at RAPID + TCT 2019
April 12 2019 20:30 JST
More Press release >>
Latest Press Release
Low Carbon on Cement Possible with CCS
Jan 22, 2021 09:04 JST
MHIET Conducts Combustion Test for Hydrogen Engine with Pure Hydrogen
Jan 21, 2021 17:38 JST
Fujitsu Delivers Cashless, Contactless Retail Experience for Masked Shoppers with Hygienic, Multi-Factor Biometric Authentication Technology
Jan 21, 2021 10:05 JST
Honda, Cruise and GM Take Next Steps Toward Autonomous Vehicle Mobility Service Business in Japan
Jan 20, 2021 11:29 JST
DENSO Collaborates with Aeva to Bring New LiDAR to Market
Jan 20, 2021 09:34 JST
Mitsubishi Corporation: Commercial Operations Commence at Methanol / Dimethyl Ether Plant in Trinidad and Tobago
Jan 19, 2021 10:25 JST
TOYOTA GAZOO Racing Targets the Top Step on Classic Season Opener
Jan 18, 2021 18:08 JST
Second Overall as Toyota Gazoo Racing Fights To the End of Dakar 2021
Jan 18, 2021 17:30 JST
SDK to increase capacity of aluminum substrate for hard disks
Jan 15, 2021 10:00 JST
Toyota Gazoo Racing Introduces GR010 Hybrid Hypercar
Jan 15, 2021 08:37 JST
New-Look Toyota Yaris Wrc Ready to Fight for More Titles in 2021
Jan 15, 2021 08:16 JST
NEC Concludes Contract to Supply the Palau Cable 2 (PC2) Optical Submarine Cable
Jan 14, 2021 14:01 JST
Fujitsu Leverages Deep Learning to Achieve World's Most Accurate Recognition of Complex Actions and Behaviors Based on Skeleton Data
Jan 13, 2021 10:55 JST
Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium
Jan 12, 2021 12:37 JST
Thailand's First Demonstration Project of Optimized Performance Enabling Network for Volt/Var(Q) (OPENVQ) in Power Transmission Networks
Jan 12, 2021 12:21 JST
NEC Releases 'WISE VISION Endoscopy' in Europe and Japan
Jan 12, 2021 10:56 JST
Norwegian Block Exchange (NBX) Raises Capital for Growth
Jan 12, 2021 07:30 JST
MHI Thermal Systems Receives 2020 "Agency for Natural Resources and Energy Commissioner's Award" for MSV2 Series of High-efficiency, Air-cooled Heat Pump Chillers
Jan 07, 2021 15:20 JST
Olympus and Hitachi Announce Long-Term Business Alliance regarding Endoscopic Ultrasound Systems
Jan 06, 2021 18:48 JST
Hitachi Automotive Systems, Keihin, Showa, and Nissin Kogyo Conclude Management Integration and Commence Operations as Hitachi Astemo
Jan 06, 2021 18:17 JST
More Latest Release >>